EN ISO 11737-1:2018/A1:2021 PDF

Overview

EN ISO 11737-1:2018/A1:2021 is Amendment 1 to ISO 11737‑1:2018, adopted by CEN to support harmonized microbiological methods for the sterilization of health care products. The standard specifies procedures for the determination of a population of microorganisms on products (commonly referred to as bioburden). This amendment updates the European adoption of the ISO document and clarifies its relationship to EU regulatory requirements (MDR 2017/745 and IVDR 2017/746).

Keywords: EN ISO 11737-1:2018/A1:2021, ISO 11737-1, bioburden, sterilization validation, microbiological methods, medical devices, MDR, IVDR.

Key topics and requirements

• Scope: Methods for determining the microbial population present on health-care products prior to sterilization (bioburden assessment).
• Purpose: Support validation and maintenance of sterilization processes and, where applicable, development/validation of processes to achieve specific microbial states other than sterility.
• Normative references: Cited standards include ISO 10012, ISO 13485, ISO 15189 and ISO/IEC 17025 (as referenced in the European foreword). Undated references imply the latest editions apply.
• Regulatory linkage: Annex ZA and ZB map the standard’s clauses to the General Safety and Performance Requirements of EU Regulations (MDR 2017/745 and IVDR 2017/746), providing a presumption of conformity for relevant requirements when the standard is cited in the Official Journal of the EU.
• Limitations: The standard addresses bioburden determination but does not cover packaging design for maintenance of sterility during transport/storage or manufacturing aspects unrelated to bioburden testing. Risk management references must be consistent with the applicable EU regulation wording.

Applications

• Sterilization validation and routine control: Establishing baseline bioburden for validation protocols and ongoing process monitoring.
• Product development: Assessing microbial load during design iterations when planning sterilization strategies.
• Quality and regulatory compliance: Demonstrating conformity with regulatory expectations for microbiological characterization of medical devices and in‑vitro diagnostic products.
• Laboratory implementation: Guidance for microbiology and testing laboratories performing product bioburden assays and for accreditation alignment (e.g., ISO/IEC 17025).

Who should use this standard

• Medical device and IVD manufacturers (quality, sterilization, R&D teams)
• Contract sterilization and microbiological testing laboratories
• Regulatory affairs professionals preparing conformity documentation for MDR/IVDR
• Accreditation bodies and notified bodies assessing sterilization validation evidence

Related standards

• ISO 11737‑2 (sterility testing methods) - complementary to Part 1
• ISO 13485 (quality management for medical devices)
• ISO/IEC 17025, ISO 15189 (laboratory competence)

Use EN ISO 11737‑1:2018/A1:2021 when establishing robust, regulatory‑aware bioburden testing programs that feed sterilization validation and ongoing process control.